(15) confirm the expression of LDHC mRNA in all tested tumor types; the corresponding reported frequencies are as follows: melanoma (7/16), breast (7/20), colon (3/20), prostate (3/8), lung (8/17), renal (4/7), ovarian (3/7), thyroid (1/4), and cervical cancers (5/6); melanoma (5/8) and lung cancer cell lines (2/6). This evidence concerns the gene LDHC and melanoma.